Accelerate Diagnostics, Inc short interest in 2023
In 2023, Accelerate Diagnostics, Inc's disclosed short interest ran from 4.50% of shares outstanding on 13 Jan 2023 to 2.80% on 29 Dec 2023, a change of -1.70 percentage points. The year's high was 5.11% on 15 Mar 2023 and its low 2.24% on 29 Sep 2023, averaging 3.67% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 31.42 days on 15 Sep 2023. Full history: Accelerate Diagnostics, Inc.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2023 in figures
- Start of year
- 4.50% (13 Jan 2023)
- End of year
- 2.80% (29 Dec 2023)
- Change
- -1.70 pp
- High
- 5.11% (15 Mar 2023)
- Low
- 2.24% (29 Sep 2023)
- Average
- 3.67%
- Highest days to cover
- 31.42 (15 Sep 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 4.50% | 15.83 | |
| 31 Jan 2023 | 4.52% | 26.77 | |
| 15 Feb 2023 | 4.54% | 20.02 | |
| 28 Feb 2023 | 4.77% | 11.53 | |
| 15 Mar 2023 | 5.11% | 12.72 | |
| 31 Mar 2023 | 4.78% | 12.01 | results (8-K), 10-K filed |
| 14 Apr 2023 | 4.88% | 28.11 | |
| 28 Apr 2023 | 4.33% | 11.63 | |
| 15 May 2023 | 4.07% | 26.58 | results (8-K), 10-Q filed |
| 31 May 2023 | 4.34% | 23.18 | |
| 15 Jun 2023 | 4.02% | 12.58 | |
| 30 Jun 2023 | 3.91% | 18.35 | |
| 15 Aug 2023 | 2.93% | 17.14 | results (8-K), 10-Q filed |
| 31 Aug 2023 | 2.89% | 28.02 | |
| 15 Sep 2023 | 2.45% | 31.42 | |
| 29 Sep 2023 | 2.24% | 16.19 | |
| 13 Oct 2023 | 2.49% | 12.46 | |
| 31 Oct 2023 | 2.79% | 27.56 | |
| 15 Nov 2023 | 2.69% | 27.20 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 3.01% | 16.93 | |
| 15 Dec 2023 | 2.70% | 6.21 | |
| 29 Dec 2023 | 2.80% | 11.82 |
See also: Accelerate Diagnostics, Inc's full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.